Navigation Links
GlaxoSmithKline's Zofran Helps In Treatment Of Dehydration In Children

The drug Zofran, commonly given in children to limit vomiting can help in the recovery of children dehydrated by viral gastroenteritis //. A latest study released on Wednesday further highlights that emergency room doctors are overusing the drug.

Childhood gastroenteritis accounts for over 1.5 million of the emergency room visits annually. Dehydrated children are being encouraged to drink an electrolyte solution for restoration of fluid electrolyte balance. However vomiting prevents most children from reaping any clinical benefit.

Administration of intravenous fluids is one alternative to enable recovery of children. Another alternative to stop the vomiting is to administer ondansetron, manufactured by GlaxoSmithKline and marketed under the brand name, Zofran, reveals a study published in the New England Journal of Medicine.

The study was conducted on children who had to be hospitalized (Children's Memorial Hospital in Chicago) for their dehydration. The study participants were divided into two groups, one group received Zofran while the other was provided a placebo. Care was taken to ensure that same number of children were included in both the groups. Severely dehydrated children were excluded from the study.

Administration of Zofran was found to reduce the need for intravenous intervention or IV therapy. As little as 14% of the 107 children treated with Zofran needed intravenous fluid administration for treatment of dehydration, while 31% of those who received a placebo needed fluid replacement in the form of IV therapy.

'Children who received ondansetron had fewer episodes of vomiting, greater oral intake of fluids and a shorter stay in the emergency department. We were seeing physicians in private hospital emergency departments that were doing this for everybody,' said Stephen Freedman who led the research team.

The distinct advantage of administering Zofran is that it is more cost-effectiv e than an IV treatment and prevents pain associated with needle picks, which is very valuable in children. For example, IV treatment of a child costs $125 at Children's Memorial Hospital, where the study was done. On the other hand, Zofran tablet, which is a quick dissolve formulation, costs $36 per tablet, substantially reducing the treatment cost.


'"/>




Related medicine news :

1. Antibiotics Helps Autism
2. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
3. Prescription Drug - Helps People Stop Smoking
4. New Drug PP188 Helps Sickle Cell Disease
5. Red Wine Helps Fight Heart disease
6. Creatine Helps Strengthen Older Men
7. Cholesterol Drug Helps After Angioplasty
8. Virus Helps Remove Brain Cancer
9. Eating Fish Helps the Heart
10. Antidepressant Helps Relieve Hot Flashes
11. Epilepsy Drug Helps Diabetic Nerve Damage
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... industry. Conventional sodium testing methods are complicated and require expert user knowledge. In ... new analytical method dedicated to the simplified, yet highly accurate, determination of sodium. ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... GTEC Orange facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year ... be an opportunity for area-residents to celebrate two great years while also familiarizing ...
(Date:3/27/2017)... Texas (PRWEB) , ... March 27, 2017 , ... Harris ... hard of hearing, is bringing its latest products to the Deaf Seniors of America ... will have the opportunity to meet with knowledgeable ASL friendly staff from Harris Communications ...
(Date:3/25/2017)... ... 25, 2017 , ... Norland at Swissray is pleased to announce the release of ... The ELITE DXA has an active scan window, which is more than double that of ... the scan area could not undergo an accurate total body bone density or body composition ...
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 ... to reach USD 16.0 billion by 2025, according to ... growing prevalence of chronic diseases is anticipated to be ... analyzers, which thereby widens the scope for growth during ... and bariatric population, which is highly susceptible to chronic ...
(Date:3/27/2017)... 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today announced that ... Bisaro as Impax,s President and Chief Executive Officer ... 27, 2017. Mr. Bisaro will succeed J. Kevin ... Chief Executive Officer since December of 2016. ... experience, Mr. Bisaro, 56, is an accomplished global business ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
Breaking Medicine Technology: